| answer text |
<p>The National Institute for Health and Care Excellence is unable to confirm a date
on which the recommendations in the COVID-19 rapid guideline on severe asthma [NG166]
will cease to be in place at this time.</p><p>COVID-19 rapid guidelines, and their
individual recommendations, will be kept under review and may be considered for withdrawal:</p><p>-
If the guideline or recommendations are no longer needed or become redundant/obsolete
because service delivery has changed (e.g. normal services have resumed), or the recommendations
are likely to have limited relevance for the service beyond the timeframe of the current
crisis;</p><p>- If there are safety issues, for example, the recommendations may harm
patients, service users or health and social care practitioners; and</p><p>- To remove
duplication of recommendations if guideline content or certain recommendations within
the COVID-19 suite are merged.</p><p> </p>
|
 |
